Webinar: Encapsulation Best Practices for Early Clinical Studies

April 05, 2018

Encapsulation Best Practices for Early Clinical Studies

Thursday, April 5th, 2pm to 3pm (EST)

Specialized capsules and encapsulation techniques can greatly simplify early studies, and play a critical role in meeting drug program timelines. Xcelodose® Precision Powder Micro-dosing Systems facilitate powder-in-capsule (PIC) / micro-dosing studies, which eliminates the need for preformulation steps and excipient compatibility testing in early clinical evaluations, is a key component of Lonza's early stage product development offering.  A set of best practices have been developed based on extensive PIC studies over a range of API characteristics to help accelerate feasibility studies and first-in-human (FIH). Representative case studies demonstrating PIC study extremes will be discussed by Lonza product development scientists.

Key Learning Objectives:

  • Understand the range of specialized capsules developed for rapid preclinical assessments, double-blind studies, enteric protection, and dry powder inhaler applications  in clinical evaluations
  • Discuss best practices for Xcelodose®-based PIC studies with challenging compounds demonstrating the full range of application across micro-dosing challenges

Presented By:

Mark Cappucci Team Leader
Preformulation Product Development Dosage Forms & Delivery Systems
Lonza Pharma & Biotech

Stephanie Sastre
Process Engineer, Operations Dosage Forms & Delivery Systems
Lonza Pharma & Biotech

Matt Richardson, Ph.D.
Manager, Business Development
Capsule Delivery Solutions
Lonza Pharma & Biotech


 

Register Now